Patents Assigned to Tandem Biotherapeutics, Inc.
  • CELL-BASED THERAPIES AND USES THEREOF
    Publication number: 20230201272
    Abstract: Aspects of the disclosure relate to compositions comprising populations of isolated amniotic cells. In some embodiments, the populations of cells are enriched for human amniotic epithelial cells (hAECs). In some embodiments, the disclosure provides methods of administering the compositions to a subject, for example a subject having certain diseases or disorders such as liver disease, phenylketonuria (PKU), a vocal cord injury or a disease associated with a Complement Factor H deficiency.
    Type: Application
    Filed: May 6, 2021
    Publication date: June 29, 2023
    Applicant: Tandem Biotherapeutics, Inc.
    Inventors: Roberto Gramignoli, Stephen Strom